while the 36-month beta value is 1.67.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 4 as “hold,” and 0 as “sell.” The average price point forecasted by analysts for Pacific Biosciences of Calif
In the past week, PACB stock has gone up by 4.84%, with a monthly gain of 31.62% and a quarterly surge of 16.30%. The volatility ratio for the week is 6.01%, and the volatility levels for the last 30 days are 6.70% for Pacific Biosciences of California Inc. The simple moving average for the past 20
, and the 36-month beta value for PACB is at 1.68. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 0 rating it as “overweight,” 4 as “hold,” and 0 as “sell.” The average price suggested by analysts for PACB is $12.38, wh
It’s Worth A Gamble To Have A Position In Pacific Biosciences of California Inc (NASDAQ: PACB) At $10 69 marketingsentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketingsentinel.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California Inc. (NASDAQ:PACB) price closed lower on Friday, March 10, dropping -5.36% below its previous close. A look at the daily price movement shows that the last close reads $8.77, with intraday deals fluctuated between $8.01 and $8.72. The company’s 5Y monthly beta was